Patents by Inventor Dharma Polisetti

Dharma Polisetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl carbonyl derivatives as therapeutic agents
    Publication number: 20080119455
    Abstract: This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 22, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Dharma Polisetti, Janos Kodra, Jesper Lau, Paw Bloch, Maria Valcarce-Lopez, Niels Blume, Mustafa Guzel, Kalpathy Santhosh, Adnan Mjalli, Robert Andrews, Govindan Subramanian, Michael Ankersen, Per Vedso, Anthony Murray, Lone Jeppesen
  • Aryl carbonyl derivatives as therapeutic agents
    Publication number: 20080119454
    Abstract: This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 22, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Dharma Polisetti, Janos Kodra, Jesper Lau, Paw Bloch, Maria Valcarce-Lopez, Niels Blume, Mustafa Guzel, Kalpathy Santhosh, Adnan Mjalli, Robert Andrews, Govindan Subramanian, Michael Ankersen, Per Vedso, Anthony Murray, Lone Jeppesen
  • Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors
    Publication number: 20070191385
    Abstract: The present invention provides imidazole derivatives of Formula (I-IV), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I-IV), and their use in treating human or animal disorders. The compounds of the invention inhibit protein tyrosine phosphatase 1B and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes.
    Type: Application
    Filed: January 30, 2007
    Publication date: August 16, 2007
    Inventors: Adnan Mjalli, Dharma Polisetti, Govindan Subramanian, James Quada, Ravindra Yarragunta, Robert Andrews, Rongyuan Xie
  • Heteroaryl-ureas and their use as glucokinase activators
    Publication number: 20070054897
    Abstract: This invention relates to compounds of formula (I) which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
    Type: Application
    Filed: June 14, 2006
    Publication date: March 8, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Anthony Murray, Jesper Lau, Lone Jeppesen, Per Vedso, Michael Ankersen, Jane Lundbeck, Marit Kristiansen, Maria Valcarce-Lopez, Dharma Polisetti, Govindan Subramanian, Robert Andrews, Daniel Christen, Jeremy Cooper, Kalpathy Santhosh
  • Aryl carbonyl derivatives as therapeutic agents
    Publication number: 20060183783
    Abstract: This invention relates to aryl carbonyl derivativeswhich are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
    Type: Application
    Filed: March 1, 2006
    Publication date: August 17, 2006
    Inventors: Dharma Polisetti, Janos Kodra, Jesper Lau, Paw Bloch, Maria Lopez, Niels Blume, Mustafa Guzel, Kalpathy Santhosh, Adnan Mjalli, Robert Andrews, Govindan Subramanian, Michael Ankersen, Per Vedso, Anthony Murray, Lone Jeppesen
  • Substituted azole derivatives, compositions, and methods of use
    Publication number: 20050187277
    Abstract: The present invention provides azole derivatives of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I), and their use in treating human or animal disorders. The compounds of the invention can be useful as inhibitors of protein tyrosine phosphatases and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes.
    Type: Application
    Filed: February 11, 2005
    Publication date: August 25, 2005
    Inventors: Adnan Mjalli, Dharma Polisetti, Govindan Subramanian, James Quada, Murty Arimilli, Ravindra Yarragunta, Robert Andrews, Rongyuan Xie